Literature DB >> 29278998

Neurocognitive and Fine Motor Deficits in Asymptomatic Adolescents during the Subacute Period after Concussion.

Richard J Servatius1,2,3, Kevin M Spiegler2, Justin D Handy1,4, Kevin C H Pang1,2, Jack W Tsao5,6, Catherine A Mazzola1,7.   

Abstract

Adolescents are at high risk for sustaining concussions. There is considerable controversy regarding the sensitivity of neurocognitive tests to detect and track dysfunction in the aftermath of concussion. Two neurocognitive test batteries were compared during the subacute phase of recovery from concussion to determine sensitivity to concussion. Adolescents (ages 11-17 years) with a concussion diagnosis (eight males, seven females, 9-69 days after injury) were recruited through a concussion clinic and compared with community nonconcussed volunteers (11 males, three females). Adolescents completed the online version of the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) on a desktop computer and the Defense Automated Neurobehavioral Assessment (DANA) on a handheld device, as well as the Grooved Pegboard Test, which assessed manual dexterity and motor speed. There were no differences in self-reported symptoms on the Post-Concussion Symptom Scale comparing concussed and nonconcussed adolescents. No significant between-groups differences were observed in ImPACT performance. Performance deficits were apparent for the DANA assessment, reflecting lower throughput scores for simple reaction time and response inhibition parameters in those with concussion. Concussed adolescents also had slower Grooved Pegboard Test performance when using the nondominant hand. Both the DANA test battery and the Grooved Pegboard Test appear to have promise as tools to detect persistent cognitive and motor dysfunction in the subacute period after concussion.

Entities:  

Keywords:  behavioral assessments; cognitive function; pediatric brain injury; traumatic brain injury

Mesh:

Year:  2018        PMID: 29278998     DOI: 10.1089/neu.2017.5314

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  6 in total

1.  Concussion and National Hockey League Player Performance: An Advanced Hockey Metrics Analysis.

Authors:  Thomas A Buckley; Kelsey N Bryk; Kathryn L Van Pelt; Steven P Broglio; Stephen A East; Scott L Zuckerman; Andrew W Kuhn
Journal:  J Athl Train       Date:  2019-04-01       Impact factor: 2.860

2.  Vergence Endurance Test: A Pilot Study for a Concussion Biomarker.

Authors:  Chang Yaramothu; Lynn D Greenspan; Mitchell Scheiman; Tara L Alvarez
Journal:  J Neurotrauma       Date:  2019-03-28       Impact factor: 5.269

3.  The Convergence Insufficiency Neuro-mechanism in Adult Population Study (CINAPS) Randomized Clinical Trial: Design, Methods, and Clinical Data.

Authors:  Tara L Alvarez; Mitchell Scheiman; Elio M Santos; Cristian Morales; Chang Yaramothu; John Vito D'Antonio-Bertagnolli; Bharat B Biswal; Suril Gohel; Xiaobo Li
Journal:  Ophthalmic Epidemiol       Date:  2019-10-22       Impact factor: 1.648

4.  Test-Retest Reliability of Functional Magnetic Resonance Imaging Activation for a Vergence Eye Movement Task.

Authors:  Cristian Morales; Suril Gohel; Xiaobo Li; Mitchell Scheiman; Bharat B Biswal; Elio M Santos; Chang Yaramothu; Tara L Alvarez
Journal:  Neurosci Bull       Date:  2019-12-23       Impact factor: 5.203

Review 5.  Impaired motor control after sport-related concussion could increase risk for musculoskeletal injury: Implications for clinical management and rehabilitation.

Authors:  Terese L Chmielewski; Justin Tatman; Shuhei Suzuki; MaryBeth Horodyski; Darcy S Reisman; Russell M Bauer; James R Clugston; Daniel C Herman
Journal:  J Sport Health Sci       Date:  2020-11-11       Impact factor: 7.179

6.  Test-retest of a phoria adaptation stimulus-induced functional MRI experiment.

Authors:  Cristian Morales; Suril Gohel; Mitchell Scheiman; Xiaobo Li; Elio M Santos; Ayushi Sangoi; Tara L Alvarez
Journal:  J Vis       Date:  2020-08-03       Impact factor: 2.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.